Fast Five Quiz: Myasthenia Gravis Treatments

Helmi L. Lutsep, MD


September 13, 2023

Myasthenia gravis (MG) is an acquired autoimmune disorder caused by an antibody-mediated blockade of neuromuscular transmission, which results in skeletal muscle weakness and rapid muscle fatigue. This relatively rare autoimmune attack occurs when autoantibodies form against the nicotinic acetylcholine postsynaptic receptors at the neuromuscular junction of skeletal muscles. Although in most cases the chief target of the autoimmune attack is the skeletal muscle nicotinic acetylcholine receptor, other antigenic targets that are components of the neuromuscular junction have also been implicated, and numerous novel treatments are available today for patients. MG is among the most treatable neurologic disorders, and success in treatment depends greatly on severity and rapidity of disease progression at the time that treatment is initiated.

Are you ready to treat MG in your patients? Test yourself with a short quiz on the range of available treatments for this condition.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.